Susan Alpert, Ph.D., M.D., is the principal of SFADC LLC (SFA Regulatory, LLC), a consulting firm focused on strategies for placing medical devices and products in global markets. She was a Senior Vice President for Global Regulatory at Medtronic and VP of Regulatory Science at C.R. Bard. Previously, she worked at the US FDA in various management roles, including Director of the Office of Device Evaluation (1993-1999). Susan is a microbiologist and pediatrician specializing in infectious diseases. She holds degrees from Barnard College, New York University, and the University of Miami. She serves on several nonprofit and for-profit boards.
The Need
Intraoperative Monitoring
is complex and
error-prone
error-prone
Only 20%
of neurosurgeries are monitored
due to expert shortage
due to expert shortage
Eroding
profit
margins
margins
Nervio's Solution
AIM™ – Effectively adds an expert neurophysiologist to the team
Intraoperative neuromonitoring (IONM) has seen no innovation in over two decades. AIM™ is the first and only AI-powered neuromonitoring solution that converts raw surgical data into real-time alerts and recommendations. Built on state-of-the-art machine learning algorithms,
the system was tested on over 1K surgeries and is a vigilant adjunct to existing systems.
Watch Video
Features
Improves data mining quality
Reduces workload
Allows expansion into untapped markets
Streamlines operations
Faster clinical alerts with clear visuals
Why is Nervio a Game Changer?
About Us
As the chief neurophysiologist at a large medical center, Dr. Omer Zarchi is challenged with providing neuromonitoring services to multiple surgeries every day.
Understaffed due to a shortage in experts and lengthy training, surgeries would occasionally be postponed or even cancelled altogether. Upon the maturation of artificial intelligence, he envisioned replicating his and other expert neurophysiologist’s knowhow into an AI software that would assist him and his team in addressing these challenges that are also encountered worldwide. Together with brother Nir, they established Nervio in early 2020 to create the AIMTM proprietary technology which is set to benefit over 700K yearly monitored surgeries in the US alone in a $3.3B market growing at 4.9% CAGR.
Executive Team
Dr. Richard Vogel
CEO, Nervio Inc.
President of the ASNM, experienced healthcare executive, a world-renowned expert in IONM and an influential thought leader. He holds PhDs in both neuroscience and psychology.
Prof. Jay Shils
Director of Clinical Affairs
Professor of Anesthesia
Rush University Medical Center.
Dr. Susan Alpert
Head, Regulatory Affairs
Clinician with a PhD in medical microbiology and 13 years at FDA with time at CDER, CDRH and CFSAN including 6 years leading the Office of Device Evaluation at CDRH.
Ariel Weinstein
CEO, Nervio Ltd.
A seasoned medical industry professional with over 25 years of experience, including 15 years in corporate leadership, possesses expertise in launching complex drug-device products. He holds an MSc in Management from NYU and a BSc in Emergency Medicine from Ben Gurion University.
Nir Zarchi
Co-Founder & Chief Product and Innovation
Seasoned entrepreneur with extensive experience in business & product development. Holds an MA in Systems Management and BSc in Industrial Management.
Dr. Omer Zarchi
Co-Founder & CSO
Head of the Intraoperative Neurophysiology Service at Rabin Medical Center and Schneider Children’s Medical Center. Holds a PhD. and MSc. in Neuroscience.
Dr. Einat Kermany
Chief Technical Officer
Expert in research and development of AI systems and deep learning algorithms.
Holds a PhD. in Neuroscience and BSc in Computer Sciences.
Advisory Board
News & Events
Partnership Network
Contact Us
US Office
(215) 534-4115
3200 West End Avenue, Suite 500, Nashville, TN 37203, USA
International Office
+972-4-6638883
Manof Industrial Park, Manof, Misgav 2018400 Israel